No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Top 2 Health Care Stocks That Are Ticking Portfolio Bombs
Trading Halt: Halted at 4:00:59 A.m. ET - Trading Halt: Halt News Pending
Mesoblast Says JPMorgan Chase Reduces Shareholding
Mesoblast Requests Trading Halt
Mesoblast Prepares to Launch FDA-approved Therapy for Pediatric Steroid-Refractory AGVHD | ASX:MSB
Mesoblast To Issue 10.2 Million Shares to Osiris Therapeutics Following US FDA Approval of Cell Treatment; Shares Fall 6%